Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Devices & Dosimetry

Chlorophyll derivative mediated PDT versus methotrexate: an in vitro study using MCF-7 cells

Compared to MTX, light activated chlorophyll derivative proved to be a better candidate for breast cancer cell toxicity, referring to its higher efficacy at tumour cells killing, safety to normal cells and simple method of extraction.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors compared light-activated chlorophyll derivative photodynamic therapy with methotrexate chemotherapy in MCF-7 breast cancer cells in vitro. They report that 50% tumour cell death was reached at a chlorophyll derivative concentration 138 times lower than methotrexate, and that the chlorophyll derivative caused no genetic side effects in normal lymphocytes, unlike methotrexate. These are laboratory cell findings only.

Who or what was studied
MCF-7 breast cancer cell line and normal human peripheral blood lymphocytes (in vitro)
Limits stated in the abstract
The study was performed in vitro on cultured cells, so the findings do not establish effects in patients.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.

Record from PubMed, a service of the National Library of Medicine.

How to read a single study: what to check before relying on this kind of research.

Terms in this paper: Photodynamic therapy. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies